New patent for Astrazeneca Ab drug BYDUREON

August 20, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…

The post New patent for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.